Doctors report breakthrough antibiotic treatment for TB.
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D024841:Fluoroquinolones; D006801:Humans; D051379:Mice; D000077266:Moxifloxacin; D011804:Quinolines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012293:Rifampin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D001372:Aza Compounds; D004338:Drug Combinations; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin; D012293:Rifampin; C018421:rifapentine